ACE rs4343: What Your Genotype Means
The rs4343 variant is a common genetic marker located within the ACE gene, which provides instructions for making the angiotensin-converting enzyme. Researchers frequently study this variant as a proxy for the well-known ACE insertion/deletion polymorphism, investigating its potential associations with blood pressure regulation and cardiovascular health.
What each genotype means
Lower ACE enzyme activity
This genotype is associated with lower baseline levels of circulating ACE enzyme compared to the GG genotype. Research suggests this variant acts as a proxy for the ACE insertion/deletion polymorphism, and carriers of the A allele may show a more stable ACE response to dietary fat intake.
This is a common genotype found in a significant portion of the global population.
Intermediate ACE enzyme activity
Carriers of this heterozygous genotype typically exhibit ACE enzyme levels that fall between those observed in AA and GG individuals. As a proxy for the ACE insertion/deletion polymorphism, this genotype represents a mixed genetic profile regarding potential cardiovascular and metabolic responses.
This is a very common genotype, frequently observed across diverse ancestral groups.
Higher ACE enzyme activity
This genotype is associated with higher baseline concentrations of circulating ACE enzyme. Research indicates that individuals with this genotype may experience a more pronounced increase in ACE levels when consuming a high-saturated-fat diet, which has been linked to potential cardiovascular risk factors in some studies.
This genotype is common, though its prevalence varies by ancestry; it is often studied as a marker for nutrigenetic responses to dietary fat.
Understanding the rs4343 Variant
The rs4343 variant is a single nucleotide polymorphism (SNP) found within the ACE gene on chromosome 17. Specifically, it is a synonymous variant, meaning that while the DNA sequence changes—typically from a guanine (G) to an adenine (A)—the resulting amino acid in the protein remains the same. Despite being synonymous, rs4343 is widely recognized in scientific literature as a proxy marker for the ACE insertion/deletion (I/D) polymorphism. This I/D polymorphism is a structural variation that has been extensively researched for its influence on the levels of circulating ACE enzyme in the blood. Because rs4343 is often inherited alongside these structural changes, scientists use it to help track how different versions of the ACE gene might influence physiological processes related to the cardiovascular system.
The Role of the ACE Gene
The ACE gene encodes the angiotensin-converting enzyme, a critical component of the renin-angiotensin-aldosterone system (RAAS). This system is the body's primary mechanism for regulating blood pressure and fluid balance. The enzyme works by converting angiotensin I into angiotensin II, a potent hormone that causes blood vessels to constrict and increases blood pressure. By modulating the activity of this enzyme, the ACE gene plays a central role in maintaining vascular tone and heart function. Variations in this gene, including those linked to rs4343, are hypothesized to influence how much ACE enzyme is produced or how efficiently it functions. Because of this central role in blood pressure control, researchers have long investigated whether specific genetic signatures in the ACE gene might predispose individuals to different cardiovascular outcomes or responses to dietary factors like sodium intake.
Research Associations and Evidence Strength
Research into rs4343 and its associated ACE polymorphisms has produced a complex and sometimes conflicting body of evidence. Many studies have explored links between these variants and conditions such as hypertension, atherosclerosis, and coronary heart disease. Some research suggests that certain alleles may be associated with higher blood pressure or increased risk of cardiovascular issues, particularly when combined with environmental factors like high salt intake. However, the evidence is considered limited and often inconsistent across different populations. Meta-analyses have shown that associations found in one ethnic group, such as European populations, are not always replicated in others, such as Asian populations. Furthermore, because rs4343 is a proxy marker, it is difficult to determine if the variant itself has a direct biological effect or if it is simply a bystander linked to other functional changes in the gene. Consequently, these findings should be viewed as statistical associations rather than definitive predictors of health.
Interpreting Your Genetic Information
It is important to understand that genetic variants like rs4343 are only one small piece of a much larger puzzle regarding cardiovascular health. Cardiovascular traits are polygenic, meaning they are influenced by hundreds of different genes, as well as significant lifestyle factors such as diet, exercise, smoking status, and stress levels. Having a specific genotype for rs4343 does not mean an individual will develop a particular condition, nor does it guarantee protection from one. This information is intended for educational purposes and should not be used to make medical decisions or self-diagnose. If you are concerned about your cardiovascular health or blood pressure, the most effective approach is to consult with a healthcare professional. They can provide a comprehensive assessment based on your clinical history, physical exams, and standard diagnostic tests, which are far more predictive of your health status than any single genetic variant.
How common is this variant?
The rs4343 variant is a common polymorphism with a minor allele frequency (MAF) of approximately 0.45 across diverse global populations, though specific frequencies vary by ancestry.
Frequently asked questions
Is rs4343 a direct cause of heart disease?
No, rs4343 is not considered a direct cause of heart disease. It is a genetic marker associated with the ACE gene, and while some studies suggest statistical links to cardiovascular traits, these associations are complex and influenced by many other genetic and environmental factors.
Can I use my rs4343 result to change my diet?
You should not make dietary changes based solely on this genetic variant. Always discuss your cardiovascular health and any potential dietary adjustments with your doctor or a registered dietitian who can evaluate your overall health profile.
Why do studies on rs4343 show different results?
Genetic research often shows different results due to variations in study design, sample sizes, and the diverse genetic backgrounds of the populations studied. Additionally, environmental factors like diet and lifestyle can mask or amplify the effects of specific genetic variants.
What should I do if I am worried about my ACE gene results?
If you have concerns about your genetic results or cardiovascular risk, the best step is to schedule an appointment with your primary care physician or a cardiologist. They can interpret your results in the context of your personal and family medical history.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4343?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ACE
This variant is associated with ACE activity levels, though current CPIC guidelines prioritize other markers for clinical ACE inhibitor dosing.
The ACE I/D polymorphism (rs1799752) is associated with circulating ACE activity, physical performance, and ACE inhibitor-induced cough.
This variant in the ACE gene is associated with variations in soluble amyloid-beta levels in patients with Alzheimer's disease.
This SNP is being investigated as a potential biomarker for personalized antihypertensive therapy in specific ethnic cohorts.
A variant recently evaluated in pharmacogenomic studies of the Pashtun population to assess its role in antihypertensive drug response.
Coding-region single nucleotide variant in the angiotensin-converting enzyme gene investigated for modulation of baseline exercise test duration and cardiovascular training response.